INOX India Limited (INOXINDIA)
Investor Presentation
Investor Presentation - Q2FY27
- Consolidated revenue 467 Cr +26.6% y-y; EBITDA 100 Cr +17.7% y-y; PAT 66 Cr +7.8% y-y
- Highest ever order booking ₹1000 Cr+ and backlog ₹2200 Cr+ in Q2FY27
- Growth impacted by aggressive pricing and higher logistics costs due to geopolitical disruptions
- Segment revenue mix: Industrial Gas 61%, LNG 15%, Cryo-Scientific 17%
- Net debt free with strong balance sheet and approx ₹384 Cr free cash
- Focus on clean energy solutions including LNG, hydrogen, fusion, and semiconductor sectors
- Global presence with manufacturing in India, Brazil, and Europe; serving 100+ countries
- Leadership in cryogenic equipment with multiple certifications and strong R&D team
- Promoters and professional management with 450+ engineers driving innovation
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 INOXINDIA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add INOXINDIA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on INOX India Limited
Important.
The summary above is generated automatically from INOX India Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.